Ultralife Corp. (ULBI) Reaches $5.98 52-Week High; Orbimed Advisors Cut Edwards Lifesciences (EW) Position By $2.03 Million

Orbimed Advisors Llc decreased Edwards Lifesciences Corp (EW) stake by 1.59% reported in 2016Q4 SEC filing. Orbimed Advisors Llc sold 21,800 shares as Edwards Lifesciences Corp (EW)’s stock declined 21.73%. The Orbimed Advisors Llc holds 1.35M shares with $126.63M value, down from 1.37 million last quarter. Edwards Lifesciences Corp now has $23.24 billion valuation. The stock declined 0.23% or $0.25 reaching $110.17 per share. About 99,647 shares traded. Edwards Lifesciences Corp (NYSE:EW) has declined 8.31% since September 28, 2016 and is downtrending. It has underperformed by 18.36% the S&P500.

The stock of Ultralife Corp. (NASDAQ:ULBI) hit a new 52-week high and has $6.16 target or 3.00% above today’s $5.98 share price. The 8 months bullish chart indicates low risk for the $95.12M company. The 1-year high was reported on May, 5 by Barchart.com. If the $6.16 price target is reached, the company will be worth $2.85M more. About 70,824 shares traded or 147.00% up from the average. Ultralife Corp. (NASDAQ:ULBI) has risen 39.02% since September 28, 2016 and is uptrending. It has outperformed by 28.98% the S&P500.

Among 25 analysts covering Edwards Lifesciences Corp (NYSE:EW), 18 have Buy rating, 1 Sell and 6 Hold. Therefore 72% are positive. Edwards Lifesciences Corp had 58 analyst reports since July 30, 2015 according to SRatingsIntel. As per Wednesday, February 3, the company rating was maintained by Canaccord Genuity. The rating was initiated by SunTrust on Friday, January 8 with “Neutral”. The stock has “Neutral” rating by BTIG Research on Thursday, February 2. The stock of Edwards Lifesciences Corp (NYSE:EW) has “Market Perform” rating given on Tuesday, April 5 by Northland Capital. BTIG Research maintained Edwards Lifesciences Corp (NYSE:EW) rating on Wednesday, July 27. BTIG Research has “Buy” rating and $130 target. The rating was upgraded by BTIG Research to “Buy” on Monday, April 4. As per Thursday, February 2, the company rating was downgraded by Leerink Swann. The stock of Edwards Lifesciences Corp (NYSE:EW) earned “Outperform” rating by RBC Capital Markets on Wednesday, February 3. BMO Capital Markets maintained it with “Outperform” rating and $114 target in Monday, April 4 report. Credit Suisse reinitiated it with “Outperform” rating and $162 target in Monday, August 10 report.

Orbimed Advisors Llc increased Allergan Plc stake by 719,690 shares to 769,690 valued at $161.64 million in 2016Q4. It also upped Hca Holdings Inc (NYSE:HCA) stake by 690,000 shares and now owns 2.00 million shares. Xencor Inc (NASDAQ:XNCR) was raised too.

Analysts await Edwards Lifesciences Corp (NYSE:EW) to report earnings on July, 25. They expect $0.88 EPS, up 15.79% or $0.12 from last year’s $0.76 per share. EW’s profit will be $185.63 million for 31.30 P/E if the $0.88 EPS becomes a reality. After $0.94 actual EPS reported by Edwards Lifesciences Corp for the previous quarter, Wall Street now forecasts -6.38% negative EPS growth.

Since November 11, 2016, it had 2 insider buys, and 0 insider sales for $393,334 activity. WHITMORE BRADFORD T had bought 33,107 shares worth $140,565 on Friday, November 11.

Investors sentiment increased to 1.2 in 2016 Q4. Its up 0.40, from 0.8 in 2016Q3. It is positive, as 4 investors sold Ultralife Corp. shares while 6 reduced holdings. 3 funds opened positions while 9 raised stakes. 3.15 million shares or 3.01% less from 3.25 million shares in 2016Q3 were reported. Bridgeway Management Inc accumulated 132,300 shares. Nationwide Fund Advsr stated it has 3,374 shares. Lsv Asset Mgmt has 0% invested in Ultralife Corp. (NASDAQ:ULBI) for 39,403 shares. 27,100 are owned by Spark Invest Management Limited. Fny Managed Accounts Ltd Liability invested 0% of its portfolio in Ultralife Corp. (NASDAQ:ULBI). Blackrock Institutional Tru Na has 80,267 shares. California Pub Employees Retirement System reported 0% of its portfolio in Ultralife Corp. (NASDAQ:ULBI). Shikiar Asset Mngmt Inc owns 24,600 shares for 0.05% of their portfolio. Blackrock Management Ltd Limited Liability Company accumulated 1,750 shares. Geode Management invested in 0% or 65,480 shares. Jacobs Levy Equity Management, a New Jersey-based fund reported 18,151 shares. Blackrock Lc holds 4,545 shares. Manufacturers Life The owns 1,160 shares for 0% of their portfolio. Creative Planning reported 2,000 shares stake. Morgan Stanley owns 1,243 shares for 0% of their portfolio.